Navigation Links
Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
Date:2/5/2008

CRANBURY, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN) will announce its second quarter, fiscal year 2008 financial results for the period ended December 31, 2007 on February 11, 2008 before the open of the U.S. financial markets.

The Company will also conduct a teleconference and live audio webcast hosted by Palatin's executive management team on February 11, 2008 at which they will discuss the results of operations in greater detail and provide an update on corporate developments.
Schedule for the Financial Results Press Release, Conference Call and Webcast

-- Q2-Fiscal Year 2008 Financial Results 2/11/2008 at 7:30 a.m. ET

Press Release

-- Q2-Fiscal Year 2008 Conference 2/11/2008 at 11:00 a.m. ET

Call - Live

Domestic Dial-In Number 1-888-686-9699

International Dial-In Number 1-913-312-6699

-- Q2-Fiscal Year 2008 Conference 2/11-2/18/2008

Call - Replay

Domestic Dial-In Number 1-888-203-1112

International Dial-In Number 1-719-457-0820

Replay Passcode: 6144795

-- Webcast Live and Replay Access http://www.palatin.com

The webcast and replay can be accessed by logging on to the "Investor

Center-Webcasts" section of Palatin's website at http://www.palatin.com.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
2. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
5. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
6. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
7. Neurobiological Technologies Sets Date for Second Quarter Financial Results
8. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
9. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
10. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
11. Genelabs Technologies, Inc. Announces Resignation of President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik ... Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. ... Foundation and administered by the New York Academy of Sciences to honor the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:5/16/2017)...  Veratad Technologies, LLC ( www.veratad.com ), an innovative ... verification solutions, announced today they will participate as a ... thru May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions ... evolving digital world, defining identity is critical to nearly ...
Breaking Biology News(10 mins):